We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich Irinotecan hydrochloride. powder, ≥97% (HPLC). 250 mg
List Price $991.80 Your Price $991.80
Sigma-Aldrich Irinotecan hydrochloride. powder, ≥97% (HPLC). 250 mg - SIAL (Additional S&H Or Hazmat Fees May Apply)
NETA PART: SIAL-I1406-250MG
MFG.PART: I1406-250MG
UNSPSC: 41116107
Manufacturer: Sigma-Aldrich


Product Name
Irinotecan hydrochloride, topoisomerase inhibitor
biological source
plant (Fructus camptothecae)
assay
≥97% (HPLC)
form
powder
solubility
DMSO: 50 mg/mL
storage temp.
2-8°C
SMILES string
Cl.CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(OC(=O)N6CCC(CC6)N7CCCCC7)cc15)[C@@](O)(CC)C(=O)OC4
InChI
1S/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1
InChI key
GURKHSYORGJETM-WAQYZQTGSA-N
Gene Information
human ... TOP1(7150)
Application
Irinotecan hydrochloride has been used:
- in combination with 5-fluorouracil for screening growth inhibitory functionality in MDA-MB-231 breast cancer cells.[1]
- in chemosensitivity screening of high-grade appendiceal (HGA) and low-grade appendiceal (LGA) organoids.[2]
- as a chemotherapeutic agent in the cytotoxicity studies in combination with heat shock proteins inhibitors (HPSC1) in HT29 colon cancer cells.[3]
Biochem/physiol Actions
The anticancer agent, irinotecan, is a prodrug that is converted by tissue carboxylesterase to 7-ethyl-10-hydroxycamptothecin (SN-38), a potent inhibitor of DNA topoisomerase I. Its action is terminated by glucuronidation by UDP glucuronosyl transferase 1A1 (UGT1A1).
The anticancer agent, irinotecan, is a prodrug that is converted by tissue carboxylesterase to 7-ethyl-10-hydroxycamptothecin (SN-38), a potent inhibitor of DNA topoisomerase I. Its action is terminated by glucuronidation by UDP glucuronosyl transferase 1A1 (UGT1A1). It proves useful in radiation treatment of tumors by sensitizing tissue to radiation damage.
The anticancer agent, irinotecan, is a prodrug that is converted by tissue carboxylesterase to 7-ethyl-10-hydroxycamptothecin (SN-38), a potent inhibitor of DNA topoisomerase I. Its action is terminated by glucuronidation by UDP glucuronosyl transferase.
pictograms
GHS07
signalword
Warning
hcodes
H302
Hazard Classifications
Acute Tox. 4 Oral
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
PPE
dust mask type N95 (US), Eyeshields, Gloves
| SKU | SIAL-I1406-250MG |
|---|---|
| Supplier Part Number | I1406-250MG |
| UM | EA |
| UNSPSC | 41116107 |
| Manufacturer | Sigma-Aldrich |
| Temperature | 2-8C |
| Refrigerated-Frozen | Y |
| ProductLine | SIAL |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 10.000000 |
| Lead Time | 9 |
| CAS Number | 100286-90-6 |
| Energy Star | No |
| Green | No |
| Controlled | N |

